From the inosine producing mutants of Brevibacterium ammoniagenes, KY 13761 was selected as a strain which produced 6-azauridine from 6-azauracil.
6-Azauridine (6AUR) (Fig. 1) is the ribosi dated compound of 6-azauracil (6AU) which is an analogue of uracil and was reported to have antimicrobial1) as well as anticancer activities. 2) Recently, interests were focused on its pharma cological activity against psoriasis.3) The microbial conversion of 6AU to 6AUR was reported using Escherichia coli4) and Streptococcus faecalis,5) however, the accumu lated amounts were relatively small as such about 1mg per ml. Recently, an efficient conversion of 6AU to 6-azauridylic acid (6AURP) by Brevibacterium ammoniagenes was reported by Tanaka 5.0mg/ml of 6AU were added after 24hr of inoculation.
KY 13716 was used. 5.0 mg/ml of 6AU were added after 24 hr of inoculation.
5.0 mg/ml of 6AU were added after 24 hr of inoculation. 
